Literature DB >> 23872300

IL-6 is a predictive biomarker for stroke associated infection and future mortality in the elderly after an ischemic stroke.

Joseph Kwan1, Gill Horsfield, Timothy Bryant, Mary Gawne-Cain, Giles Durward, Christopher D Byrne, Nicola A Englyst.   

Abstract

BACKGROUND AND
PURPOSE: Stroke associated infection (within the first seven days) occurs in approximately half of stroke patients and is associated with a worse prognosis, especially in the elderly. It is uncertain what factors predict stroke associated infection, yet identification of a suitable biomarker for infection may allow early and appropriate intervention with antibiotics. The aims of this study were to: a) identify independent risk factors for stroke associated infection, and b) test relationships between these risk factors and mortality at 2 years.
METHODS: Eight-two elderly patients were assessed within 72 h of stroke. Data on stroke severity (Barthel Index), stroke associated infection and mortality at 2 years were collected. Inflammatory biomarkers at baseline and 6 months were measured by ELISA. Logistic regression was used to identify risk factors for stroke associated infection and death.
RESULTS: Patients with stroke associated infection, especially pneumonia, had increased IL-6, more severe strokes, and higher mortality. IL-6 was independently associated with stroke associated infection (OR = 19.2, [95%CI 3.68, 100], p < 0.001), after adjustment for other risk factors and cytokines. IL-6 was also independently associated with 2 year mortality (OR = 9.2, [1.0, 85.1], p = 0.031).
CONCLUSIONS: These data suggest that IL-6 may be a key biomarker for predicting stroke associated infection and mortality in the first two years post stroke.
© 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  95% CIs; 95% confidence intervals; BI; BMI; BP; Barthel Index; Biomarker; Blood pressure; Body mass index; CT; Computed tomography; HPAA; Hypothalamic–pituitary–adrenal axis; IL-6; Infection; Modified Rankin score; Mortality; NIHSS; National Institute of Health Stroke Score; OR; Odds ratios; Risk factors; SAI; Stroke; Stroke associated infection; mRS

Mesh:

Substances:

Year:  2013        PMID: 23872300     DOI: 10.1016/j.exger.2013.07.003

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  32 in total

1.  Significance of decreased serum interleukin-10 levels in the progression of cerebral infarction.

Authors:  Zeng-Yan Diao; Cui-Lan Wang; Hong-Shun Qi; Guo-Yong Jia; Chuan-Zhu Yan
Journal:  Clin Exp Med       Date:  2015-04-07       Impact factor: 3.984

2.  Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia - The PREDICT study.

Authors:  Sarah Hoffmann; Hendrik Harms; Lena Ulm; Darius G Nabavi; Bruno-Marcel Mackert; Ingo Schmehl; Gerhard J Jungehulsing; Joan Montaner; Alejandro Bustamante; Marcella Hermans; Frank Hamilton; Jos Göhler; Uwe Malzahn; Carolin Malsch; Peter U Heuschmann; Christian Meisel; Andreas Meisel
Journal:  J Cereb Blood Flow Metab       Date:  2016-10-14       Impact factor: 6.200

3.  Functional improvement and immune-inflammatory cytokines profile of ischaemic stroke patients after treatment with boswellic acids: a randomized, double-blind, placebo-controlled, pilot trial.

Authors:  Somayeh Mahmoodi Baram; Saeed Karima; Somayeh Shateri; Abbas Tafakhori; Akbar Fotouhi; Behnam Safarpour Lima; Shima Rajaei; Meisam Mahdavi; Hessam Sepasi Tehrani; Vajiheh Aghamollaii; Seyed Hossein Aghamiri; Behnam Mansouri; Sina Gharahje; Samaneh Kabiri; Maryamosadat Hosseinizadeh; Shima Zare Shahamati; Amir Taher Alborzi
Journal:  Inflammopharmacology       Date:  2019-08-12       Impact factor: 4.473

Review 4.  Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns.

Authors:  Alejandro Bustamante; Alba Simats; Andrea Vilar-Bergua; Teresa García-Berrocoso; Joan Montaner
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

5.  Inflammatory cytokines and cells are potential markers for patients with cerebral apoplexy in intensive care unit.

Authors:  Jianhong Wang; Zicheng Hu; Shu Yang; Chengchun Liu; Haimei Yang; Duozi Wang; Fuqiang Guo
Journal:  Exp Ther Med       Date:  2018-05-23       Impact factor: 2.447

6.  Routine hematological parameters are associated with short- and long-term prognosis of patients with ischemic stroke.

Authors:  Luo Fan; Li Gui; Er-Qing Chai; Chao-Jun Wei
Journal:  J Clin Lab Anal       Date:  2017-05-22       Impact factor: 2.352

7.  Therapeutic effectiveness of a single exercise session combined with WalkAide functional electrical stimulation in post-stroke patients: a crossover design study.

Authors:  Viviane Rostirola Elsner; Lucieli Trevizol; Isadora de Leon; Marcos da Silva; Thayná Weiss; Milena Braga; Daniela Pochmann; Amanda Stolzenberg Blembeel; Caroline Dani; Elenice Boggio
Journal:  Neural Regen Res       Date:  2021-05       Impact factor: 5.135

Review 8.  Neuroinflammation and fibrosis in stroke: The good, the bad and the ugly.

Authors:  Narayanappa Amruta; Abir A Rahman; Emmanuel Pinteaux; Gregory Bix
Journal:  J Neuroimmunol       Date:  2020-07-09       Impact factor: 3.478

Review 9.  Interleukin-1 and acute brain injury.

Authors:  Katie N Murray; Adrian R Parry-Jones; Stuart M Allan
Journal:  Front Cell Neurosci       Date:  2015-02-06       Impact factor: 5.505

Review 10.  Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections.

Authors:  Júlia Faura; Alejandro Bustamante; Francesc Miró-Mur; Joan Montaner
Journal:  J Neuroinflammation       Date:  2021-06-06       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.